BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 24854110)

  • 21. Simvastatin enhances myocardial angiogenesis induced by vascular endothelial growth factor gene transfer.
    Siddiqui AJ; Gustafsson T; Fischer H; Widegren U; Hao X; Mansson-Broberg A; Grinnemo KH; Dellgren G; Sylvén C
    J Mol Cell Cardiol; 2004 Dec; 37(6):1235-44. PubMed ID: 15572054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rosuvastatin elicits KDR-dependent vasculogenic response of human placental stem cells through PI3K/AKT pathway.
    Cantoni S; Cavallini C; Bianchi F; Bonavita F; Vaccari V; Olivi E; Frascari I; Tassinari R; Valente S; Lionetti V; Ventura C
    Pharmacol Res; 2012 Mar; 65(3):275-84. PubMed ID: 22207243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atorvastatin reduces myocardial fibrosis in a rat model with post-myocardial infarction heart failure by increasing the matrix metalloproteinase-2/tissue matrix metalloproteinase inhibitor-2 ratio.
    An Z; Yang G; He YQ; Dong N; Ge LL; Li SM; Zhang WQ
    Chin Med J (Engl); 2013; 126(11):2149-56. PubMed ID: 23769575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rosuvastatin restores superoxide dismutase expression and inhibits accumulation of oxidized LDL in the aortic arch of obese dyslipidemic mice.
    Verreth W; De Keyzer D; Davey PC; Geeraert B; Mertens A; Herregods MC; Smith G; Desjardins F; Balligand JL; Holvoet P
    Br J Pharmacol; 2007 Jun; 151(3):347-55. PubMed ID: 17384667
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of rosuvastatin on cardiovascular morphology and function in an ApoE-knockout mouse model of atherosclerosis.
    Grönros J; Wikström J; Brandt-Eliasson U; Forsberg GB; Behrendt M; Hansson GI; Gan LM
    Am J Physiol Heart Circ Physiol; 2008 Nov; 295(5):H2046-53. PubMed ID: 18790840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased acinar damage of salivary glands of patients with Sjögren's syndrome is paralleled by simultaneous imbalance of matrix metalloproteinase 3/tissue inhibitor of metalloproteinases 1 and matrix metalloproteinase 9/tissue inhibitor of metalloproteinases 1 ratios.
    Pérez P; Kwon YJ; Alliende C; Leyton L; Aguilera S; Molina C; Labra C; Julio M; Leyton C; González MJ
    Arthritis Rheum; 2005 Sep; 52(9):2751-60. PubMed ID: 16142742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rosuvastatin activates ATP-binding cassette transporter A1-dependent efflux ex vivo and promotes reverse cholesterol transport in macrophage cells in mice fed a high-fat diet.
    Shimizu T; Miura S; Tanigawa H; Kuwano T; Zhang B; Uehara Y; Saku K
    Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2246-53. PubMed ID: 25104799
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of biphasic electrical current stimulation on IL-1β-stimulated annulus fibrosus cells using in vitro microcurrent generating chamber system.
    Kim JH; Choi H; Suh MJ; Shin JH; Hwang MH; Lee HM
    Spine (Phila Pa 1976); 2013 Oct; 38(22):E1368-76. PubMed ID: 23823576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rosuvastatin reduces microglia in the brain of wild type and ApoE knockout mice on a high cholesterol diet; implications for prevention of stroke and AD.
    Famer D; Wahlund LO; Crisby M
    Biochem Biophys Res Commun; 2010 Nov; 402(2):367-72. PubMed ID: 20946880
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recanalization of arterial thrombus, and inhibition with beta-radiation in a new murine carotid occlusion model: MRNA expression of angiopoietins, metalloproteinases, and their inhibitors.
    Raymond J; Lebel V; Ogoudikpe C; Metcalfe A; Chagnon M; Robledo O
    J Vasc Surg; 2004 Dec; 40(6):1190-8. PubMed ID: 15622374
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Matrix-Metallo-Proteinases and their tissue inhibitors in radiation-induced lung injury.
    Yang K; Palm J; König J; Seeland U; Rosenkranz S; Feiden W; Rübe C; Rübe CE
    Int J Radiat Biol; 2007 Oct; 83(10):665-76. PubMed ID: 17729161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduction of Adipose Tissue Mass by the Angiogenesis Inhibitor ALS-L1023 from Melissa officinalis.
    Park BY; Lee H; Woo S; Yoon M; Kim J; Hong Y; Lee HS; Park EK; Hahm JC; Kim JW; Shin SS; Kim MY; Yoon M
    PLoS One; 2015; 10(11):e0141612. PubMed ID: 26599360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Statins inhibit cyclooxygenase-2 and matrix metalloproteinase-9 in human endothelial cells: anti-angiogenic actions possibly contributing to plaque stability.
    Massaro M; Zampolli A; Scoditti E; Carluccio MA; Storelli C; Distante A; De Caterina R
    Cardiovasc Res; 2010 May; 86(2):311-20. PubMed ID: 19946014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TIMP-2 mutant decreases MMP-2 activity and augments pressure overload induced LV dysfunction and heart failure.
    Givvimani S; Kundu S; Narayanan N; Armaghan F; Qipshidze N; Pushpakumar S; Vacek TP; Tyagi SC
    Arch Physiol Biochem; 2013 May; 119(2):65-74. PubMed ID: 23398532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Statins and angiogenesis: is it about connections?
    Khaidakov M; Wang W; Khan JA; Kang BY; Hermonat PL; Mehta JL
    Biochem Biophys Res Commun; 2009 Sep; 387(3):543-7. PubMed ID: 19615978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis.
    Kossakowska AE; Edwards DR; Lee SS; Urbanski LS; Stabbler AL; Zhang CL; Phillips BW; Zhang Y; Urbanski SJ
    Am J Pathol; 1998 Dec; 153(6):1895-902. PubMed ID: 9846979
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered gene expression levels of matrix metalloproteinases and their inhibitors in periodontitis-affected gingival tissue.
    Kubota T; Itagaki M; Hoshino C; Nagata M; Morozumi T; Kobayashi T; Takagi R; Yoshie H
    J Periodontol; 2008 Jan; 79(1):166-73. PubMed ID: 18166107
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistochemical study of matrix metalloproteinases-2 and -9, macrophage inflammatory protein-2 and tissue inhibitors of matrix metalloproteinases-1 and -2 in normal, purulonecrotic and fungal infected equine corneas.
    Boveland SD; Moore PA; Mysore J; Krunkosky TM; Dietrich UM; Jarrett C; Paige Carmichael K
    Vet Ophthalmol; 2010 Mar; 13(2):81-90. PubMed ID: 20447025
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tissue inhibitor of metalloproteinases protect blood-brain barrier disruption in focal cerebral ischemia.
    Fujimoto M; Takagi Y; Aoki T; Hayase M; Marumo T; Gomi M; Nishimura M; Kataoka H; Hashimoto N; Nozaki K
    J Cereb Blood Flow Metab; 2008 Oct; 28(10):1674-85. PubMed ID: 18560439
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppression of atherosclerotic plaque progression and instability by tissue inhibitor of metalloproteinase-2: involvement of macrophage migration and apoptosis.
    Johnson JL; Baker AH; Oka K; Chan L; Newby AC; Jackson CL; George SJ
    Circulation; 2006 May; 113(20):2435-44. PubMed ID: 16702468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.